First Quadrant’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,909	Closed	-$620K	–	866
2020 Q1	$620K	Sell	6,909 -3,808	-36%	-$374K	0.09%	228
2019 Q4	$1.16M	Buy	10,717 +707	+7%	+$75.6K	0.1%	206
2019 Q3	$980K	Sell	10,010 -11,316	-53%	-$1.28M	0.09%	232
2019 Q2	$2.79M	Buy	21,326 +14,417	+209%	+$1.86M	0.19%	132
2019 Q1	$934K	Sell	6,909 -588	-8%	-$73.1K	0.07%	275
2018 Q4	$730K	Hold	7,497	–	–	0.06%	279
2018 Q3	$1.04M	Hold	7,497	–	–	0.02%	386
2018 Q2	$931K	Buy	7,497 +2,400	+47%	+$280K	0.02%	410
2018 Q1	$568K	Sell	5,097 -2,531	-33%	-$303K	0.01%	475
2017 Q4	$912K	Sell	7,628 -155,891	-95%	-$19M	0.02%	453
2017 Q3	$22.9M	Sell	163,519 -7,927	-5%	-$1.08M	0.44%	63
2017 Q2	$20.9M	Buy	+171,446	New	+$20M	0.42%	72
2015 Q2	–	Sell	-149,000	Closed	-$25.8M	–	816
2015 Q1	$25.8M	Buy	149,000 +148,000	+14,800%	+$26.8M	0.54%	57
2014 Q4	$185K	Buy	+1,000	New	+$185K	﹤0.01%	536
2014 Q3	–	Sell	-13,676	Closed	-$2.14M	–	849
2014 Q2	$2.14M	Sell	13,676 -77,000	-85%	-$12.2M	0.05%	303
2014 Q1	$13.8M	Buy	90,676 +43,600	+93%	+$6.93M	0.31%	100
2013 Q4	$6.26M	Hold	47,076	–	–	0.15%	172
2013 Q3	$5.47M	Buy	+47,076	New	+$5.16M	0.14%	183